4/A//SEC Filing
Zung Jonathan B. 4/A
Accession 0001694665-21-000029
CIK 0001694665other
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 5:07 PM ET
Size
7.8 KB
Accession
0001694665-21-000029
Insider Transaction Report
Form 4/AAmended
Zung Jonathan B.
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-01-27+300,000→ 300,000 totalExercise: $16.65Exp: 2031-01-27→ Common Stock (300,000 underlying) - Award
Restricted Stock Units
2021-01-27+10,000→ 10,000 totalExercise: $0.00→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]This option will vest as to 25% of the total grant on January 4, 2022 and as to the remaining 75% vesting thereafter in thirty-six (36) substantially equal monthly installments, subject to continued employment on such dates.
- [F2]These Restricted Stock Units will vest in full on the third anniversary of the grant date, January 27, 2024, subject to continued employment on such date.
Documents
Issuer
Evelo Biosciences, Inc.
CIK 0001694665
Entity typeother
Related Parties
1- filerCIK 0001837972
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 5:07 PM ET
- Size
- 7.8 KB